Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05023655
Title Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Prisma Health-Upstate
Indications

Advanced Solid Tumor

Therapies

Tazemetostat

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Prisma Health Cancer Institute Recruiting Greenville South Carolina 29605 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field